Gut stem cells go into overdrive with age—now scientists see a way to restrain their growth
Researchers found that intestinal stem cells tend to proliferate excessively as organisms age. This overactivity is a sign of disrupted gut regulation, not simply a stronger ability to repair tissue. The scientists reported the pattern in human samples, mice, and fruit flies, suggesting it is shared across these species. In fruit flies, the team linked this growth to ADAR, an RNA-editing enzyme that helps keep intestinal stem-cell populations balanced. When the fly enzyme was missing from these cells, they multiplied excessively and the gut tissue aged rapidly. The researchers also found that ADAR’s protective activity declined with age and after gut injury. Normally, intestinal stem cells remain quiet unless tissue needs repair. Age-related loss of this restraint can prompt cell division without an injury to fix, disrupting gut function. The findings identify stem-cell overgrowth as a marker of aging, while suggesting that ADAR-related regulation may offer a way to limit it. The human and mouse results support further study, but do not establish a treatment.
What change in intestinal stem cells did researchers observe as organisms age?
Researchers found that intestinal stem cells tend to proliferate excessively as organisms age. This overactivity is a sign of disrupted gut regulation, not simply a stronger ability to repair tissue. The scientists reported the pattern in human samples, mice, and fruit flies, suggesting it is shared across these species.
In fruit flies, the team linked this growth to ADAR, an RNA-editing enzyme that helps keep intestinal stem-cell populations balanced. When the fly enzyme was missing from these cells, they multiplied excessively and the gut tissue aged rapidly. The researchers also found that ADAR’s protective activity declined with age and after gut injury.
Normally, intestinal stem cells remain quiet unless tissue needs repair. Age-related loss of this restraint can prompt cell division without an injury to fix, disrupting gut function. The findings identify stem-cell overgrowth as a marker of aging, while suggesting that ADAR-related regulation may offer a way to limit it. The human and mouse results support further study, but do not establish a treatment.
What is ADAR, and what does it do to RNA?
ADAR stands for adenosine deaminase acting on RNA. It is a family of enzymes that chemically edits RNA, changing one building block, adenosine, into another, inosine. This process is called A-to-I RNA editing. The study examined whether this editing could help control the excessive growth of intestinal stem cells.
In fruit flies, the researchers found that ADAR helps maintain balance in intestinal stem-cell populations. It edits RNA instructions for a protein called Pumilio. Through this route, ADAR inhibits proliferative MAPK signaling, a molecular cascade that normally drives cell division. When the fly version of ADAR was lost in intestinal stem cells, those cells multiplied excessively.
The team also examined human and mouse material. Lower levels of colonic ADAR2 were associated with aging in human colon samples and with tissue regeneration after colon injuries in mice. The results point to a conserved role for ADAR-related regulation, but the authors say mammalian genetic models and patient-derived organoids are still needed to assess its targets and therapeutic potential.
How many species were represented in the study, and which ones?
The researchers represented three species in their work: humans, mice, and fruit flies. The article describes human stem cells and colon samples, mouse samples, and experiments using Drosophila melanogaster, the fruit fly. Most of the tests on ADAR’s activity in intestinal stem cells relied on fruit flies.
The fly experiments let the team alter ADAR in intestinal stem cells. Removing the enzyme triggered excessive cell proliferation and rapid tissue aging, while increasing its expression was associated with better intestinal function and longer life spans. The researchers also examined colonic ADAR2 in human samples and tissue regeneration after colon injuries in mice.
Across these different study materials, the findings suggest that ADAR-mediated regulation of intestinal stem cells is conserved. That means the researchers saw related patterns across species, not that every mechanism has been fully established in each one. The authors say further mammalian genetic studies and patient-derived organoids are needed to clarify the molecular targets and possible relevance to human aging and regenerative medicine.
What happened to gut tissue and lifespan in fruit flies when intestinal stem cells had less ADAR?
When intestinal stem cells in fruit flies lacked their version of ADAR, they proliferated excessively and the gut tissue aged rapidly. The researchers described this as a loss of control over stem-cell growth. The result fits the study’s broader finding that excessive intestinal stem-cell proliferation is associated with aging and gut dysfunction.
ADAR normally helps restrain cell division by editing RNA instructions for Pumilio. This action inhibits MAPK signaling components that promote proliferation. When ADAR was lost specifically in the flies’ intestinal stem cells, the protective restraint was disrupted, and the cells overgrew.
The article reports longer life spans for flies engineered to overexpress ADAR, but it does not state that ADAR loss directly shortened the lifespan of the tested flies. It does explain more broadly that intestinal dysregulation is associated with shortened life span. The fly results show rapid tissue aging after ADAR loss; whether that specific intervention shortened lifespan is not reported here.
How did increasing ADAR affect fruit flies’ intestinal function and lifespan?
Fruit flies engineered to overexpress ADAR had longer life spans and better intestinal function than flies without that increase, according to the study. This result is notable because the researchers also found that ADAR’s protective activity declines with age and after gut injuries.
The team’s proposed mechanism involves RNA editing. ADAR edits RNA instructions for Pumilio, and this helps inhibit MAPK signaling components that drive cell division. In the fly experiments, the enzyme acted as a restraint on intestinal stem-cell proliferation. Too little ADAR led to excessive cell growth and rapid tissue aging; more ADAR was associated with healthier gut function and longer life.
The findings suggest ADAR may be a conserved safeguard, but the evidence does not establish that increasing it would extend life in people. The researchers found related ADAR2 patterns in human colon samples and in mouse tissue regeneration after injury. They call for mammalian genetic models and patient-derived organoids to test the mechanism and its therapeutic potential.
What does it mean for a stem cell to be quiescent, and why is that state useful in the gut?
A quiescent stem cell is in a quiet state rather than actively proliferating. The article describes intestinal stem cells as usually remaining quiescent under normal conditions. They activate when needed to repair injured tissue, rather than dividing continuously.
That restraint matters in the gut because it helps keep stem-cell populations in balance. The study found that ADAR helps maintain this balance and that loss of intestinal stem-cell quiescence promotes excessive growth. In fruit flies, removing ADAR from intestinal stem cells triggered hyperproliferation and rapid tissue aging.
With age, the self-restraint mechanism weakens, the researchers report. Stem cells can then proliferate even when there is no injury to repair, disrupting intestinal function and compromising tissue repair. The findings suggest that maintaining appropriate quiescence could help protect gut tissue, though the study does not establish a treatment. The authors call for further studies in mammalian models and patient-derived organoids.
How can MAPK signaling encourage cells to divide, and how does ADAR help put a brake on it?
MAPK signaling is a molecular cascade that normally drives cell division. When this pathway promotes proliferation, cells receive signals to grow and multiply. The researchers found that ADAR inhibited proliferative MAPK signaling in intestinal stem cells, helping keep their growth in check.
The proposed link runs through Pumilio, a protein. ADAR edits the RNA instructions for Pumilio by converting adenosine to inosine. The study reports that this editing lets ADAR put the brakes on key MAPK signaling components. When intestinal stem cells in fruit flies lost ADAR, they showed excessive proliferation and the gut tissue aged rapidly.
The results connect RNA editing to control of a growth-promoting pathway in the gut. The team also found age-related reductions in colonic ADAR2 in human colon samples and associations involving mouse tissue regeneration after injury. However, the authors say more mammalian genetic models and patient-derived organoids are needed to fully establish the conserved targets and therapeutic potential.
This brief was written by AI from the original reporting and checked by other models. Names, figures and quotes come from the source; read it for full context.
Read more in the JupiteX app
Pulse is free. New stories every 4 hours, each one broken into the questions that explain it.
Or read more news on the web